Whilst our own randomised controlled pre-surgical window study did not demonstrate reduced endometrial cancer cell proliferation in response to metformin exposure, as measured by immunohistochemical expression of Ki-67, this does not preclude a specific effect of the drug on endometrial cancer stem cells [39]. This evidence concerns the gene MKI67 and endometrial cancer.